Validating tablet perimetry against standard Humphrey Visual Field Analyzer for glaucoma screening in Indian population
Parul Ichhpujani, Sahil Thakur, Roopjit K Sahi and 1 more
Indian Journal of Ophthalmology · 2021
doi:10.4103/ijo.ijo_1847_19 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Purpose: The aim of this study was to determine the correlation between the perimetric outcomes using a free application program of the iPad, 'Visual Fields Easy' (VFE), and Humphrey Visual Field Analyzer (HVFA), in normal as well as eyes with glaucomatous damage of varying severity. Methods: In this prospective, cross-sectional, observational pilot investigation, visual field testing was carried out in 210 eyes of 210 patients (60 Normal, 150 Glaucoma), using suprathreshold VFE application (Version 8) on the iPad and Standard White-on-White using HVFA. Severity of glaucoma was categorized using Hodapp-Anderson-Parrish criteria for visual field defects. The results of the VFE program were compared to the 24-2 SITA FAST HVFA. Results: Data of 210 patients, 100 (47.6%) females, and 110 (52.4%) males, age ranging from 42 to 78 years, Mean 56.64 ± 10.67 years, was analyzed. The Spearman correlation coefficient showed a significant inverse relationship between missed points on the VFE app with MD (S = –0.783) and a parabolic relationship with PSD (S = 0.646) values obtained with the HVFA. As regards missed points, for mild glaucoma, missed points were 37.5, sensitivity was 77.8% and specificity was 52.6%; for moderate glaucoma, missed points were 33.5, sensitivity was 90% and specificity was 48% while for severe glaucoma, missed points were 23, sensitivity was 97% and specificity was 70%. AROC for eyes with mild glaucoma versus normal was 0.419 (95% CI: 0.343-0.495), moderate glaucoma versus normal was 0.705 (95% CI: 0.630-0.780) and severe glaucoma versus normal was 0.857 (95% CI: 0.806-0.908). Conclusion: Suprathreshold perimetry using VFE is not suitable as a rapid screening tool for mass screening of glaucoma. VFE cannot be used as a substitute for HVFA in clinic because of its inability to detect early or moderate glaucoma.
Abstract licence: CC BY-NC-SA
References15
15 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.